IP Library › Granted Patent US 12,521,560
Granted Patent B2
US 12,521,560 · App. 17/392,585 · Granted Jan 13, 2026

Medical device and method for enabling a cardiac monitoring feature

Inventors: Michelle M. Galarneau (Minneapolis, MN); Saul E. Greenhut (Denver, CO); Yanina Grinberg (Plymouth, MN); Todd J. Sheldon (North Oaks, MN)
Assignee: Medtronic, Inc.
A61N1/3714
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,521,560
App. No.
17/392,585
Granted
Jan 13, 2026
Kind
B2
Abstract

A medical device is configured to sense a cardiac signal, determine a monitoring metric representative of activity of at least one heart chamber from the sensed cardiac signal, and determine that the monitoring metric meets expected rhythm criteria. The medical device may enable a monitoring feature of the medical device that is based on processing and analysis of the cardiac signal in response to the monitoring metric meeting the expected rhythm criteria.

Claims (149)

1 . A medical device comprising:

a first sensing circuit configured to sense a first cardiac signal; and

a control circuit configured to:

determine a monitoring metric representative of activity of at least one heart chamber from the first cardiac signal;

determine if the monitoring metric meets expected rhythm criteria by determining if the monitoring metric meets atrioventricular conduction criteria;

in response to determining that the monitoring metric meets the atrioventricular conduction criteria:

determine that the first cardiac signal is reliable for use by a monitoring feature of the medical device; and

enable at least one monitoring feature of the medical device that is based on processing and analysis of the first cardiac signal by at least enabling an atrioventricular block monitoring feature;

or

in response to determining that the monitoring metric does not meet the atrioventricular conduction criteria:

determine that the first cardiac signal is not reliable for use by a monitoring feature of the medical device; and

disable at least one monitoring feature of the medical device by at least disabling the atrioventricular block monitoring feature.

2 . The medical device of claim 1 , wherein the control circuit is configured to:

determine a first event monitoring threshold by:

determining the monitoring metric from the first cardiac signal sensed during a first time interval; and

determining the first event monitoring threshold based on the determined monitoring metric;

redetermine the monitoring metric from the first cardiac signal sensed during a second time interval after the first time interval; and

determine that the redetermined monitoring metric meets the expected rhythm criteria based on a comparison of the redetermined monitoring metric to the first event monitoring threshold.

3 . The medical device of claim 1 , wherein the control circuit is configured to determine the monitoring metric by determining an integration metric of the first cardiac signal by summing sample points of the first cardiac signal sensed over an integration time period comprising a plurality of cardiac cycles.

4 . The medical device of claim 3 , wherein the control circuit is further configured to:

determine an atrial rate; and

determine the monitoring metric by normalizing the integration metric by the atrial rate.

5 . The medical device of claim 3 , wherein the control circuit is configured to:

determine a first event monitoring threshold by:

determining the integration metric from the first cardiac signal over each one of a plurality of integration time intervals occurring within a first time interval, where each one of the plurality of integration time intervals extends over a plurality of cardiac cycles; and

determining the first event monitoring threshold based on the integration metrics determined from the first cardiac signal sensed over the first time interval;

re-determine the integration metric from the first cardiac signal sensed over at least one integration time interval occurring during a second time interval after the first time interval;

determine that the re-determined integration metric is greater than the first event monitoring threshold; and

determine that the expected rhythm criteria are met in response to the re-determined integration metric being greater than the first event monitoring threshold.

6 . The medical device of claim 5 , wherein the control circuit is further configured to set the first event monitoring threshold by:

identifying a minimum integration metric from the integration metrics determined over each one of the plurality of integration time intervals occurring during the first time interval; and

setting the event monitoring threshold based on the minimum integration metric.

7 . The medical device of claim 1 , wherein the control circuit is configured to determine the monitoring metric by:

identifying a plurality of ventricular events from the first cardiac signal; and

determining the monitoring metric based on the identified plurality of ventricular events by determining at least one of:

a ventricular event rate;

an atrioventricular time interval; and

a ratio of a count of the plurality of ventricular events to a count of atrial events occurring over a time interval comprising the identified plurality of ventricular events.

8 . The medical device of claim 7 , wherein the control circuit is configured to:

set an event monitoring threshold; and

identify the plurality of ventricular events from the first cardiac signal based on the first cardiac signal crossing the event monitoring threshold.

9 . The medical device of claim 8 , wherein the control circuit is configured to set the event monitoring threshold by:

setting a blanking interval in response to each of the plurality of atrial events

determining a maximum amplitude of the first cardiac signal outside the blanking interval; and

setting the event monitoring threshold based on the maximum amplitude.

10 . The medical device of claim 1 , wherein the control circuit is configured to:

set a first event monitoring threshold;

determine the monitoring metric from the first cardiac signal sensed during a first time interval;

determine, based on the first event monitoring threshold, that the monitoring metric determined from the first cardiac signal sensed during the first time interval does not meet the expected rhythm criteria;

adjust the first event monitoring threshold to a second event monitoring threshold;

re-determine the monitoring metric from the first cardiac signal sensed during a second time interval after the first time interval;

determine, based on the second event monitoring threshold, that the re-determined monitoring metric determined from the first cardiac signal sensed during the second time interval meets the expected rhythm criteria; and

enable the at least one monitoring feature of the medical device in response to the redetermined monitoring metric meeting the expected rhythm criteria.

11 . The medical device of claim 1 , further comprising a second sensing circuit configured to sense a second cardiac signal different than the first cardiac signal, wherein the control circuit is configured to:

determine that the monitoring metric determined from the first cardiac signal does not meet the expected rhythm criteria;

determine a second monitoring metric from the second cardiac signal;

determine that the second monitoring metric meets the expected rhythm criteria; and

enable the at least one monitoring feature of the medical device based on processing and analysis of the second cardiac signal in response to the second monitoring metric meeting the expected rhythm criteria.

12 . The medical device of claim 1 , wherein:

the first sensing circuit comprises an accelerometer for sensing the first cardiac signal as an acceleration signal.

13 . The medical device of claim 1 , wherein:

the first sensing circuit is configured to sense the first cardiac signal as a cardiac electrical signal; and

the control circuit is configured to:

set an event monitoring threshold by setting a far field R-wave detection threshold;

sense far field R-waves from the cardiac electrical signal; and

determine the monitoring metric based on the sensed far field R-waves.

14 . The medical device of claim 1 , further comprising:

a second sensing circuit configured to sense a second cardiac signal different than the first cardiac signal;

wherein the control circuit is configured to:

determine that the second cardiac signal meets second expected rhythm criteria; and

enable the at least one monitoring feature of the medical device that is based on processing and analysis of the first cardiac signal and the second cardiac signal in response to the monitoring metric determined from the first cardiac signal meeting the expected rhythm criteria and the second cardiac signal meeting the second expected rhythm criteria.

15 . The medical device of claim 1 , wherein the control circuit is further configured to enable at least one monitoring feature by enabling one of a cardiac capture monitoring feature, an oversensing monitoring feature, and a cardiac event undersensing monitoring feature.

16 . A method, comprising:

sensing a first cardiac signal determining a monitoring metric representative of activity of at least one heart chamber from the first cardiac signal;

determining if the monitoring metric meets expected rhythm criteria by determining if the monitoring metric meets atrioventricular conduction criteria; and

in response to the monitoring metric meeting the atrioventricular conduction criteria:

determining that the first cardiac signal is reliable for use by a monitoring feature of the medical device; and

enabling a monitoring feature of the medical device that is based on processing and analysis of the first cardiac signal by at least enabling an atrioventricular block monitoring feature;

or

in response to determining that the monitoring metric does not meet the atrioventricular conduction criteria:

determining that the first cardiac signal is not reliable for use by a monitoring feature of the medical device; and

disabling at least one monitoring feature of the medical device by at least disabling the atrioventricular block monitoring feature.

17 . The method of claim 16 , comprising:

determining a first event monitoring threshold by:

determining the monitoring metric from the first cardiac signal sensed during a first time interval; and

determining the first event monitoring threshold based on the determined monitoring metric;

redetermining the monitoring metric from the first cardiac signal sensed during a second time interval after the first time interval; and

determining that the redetermined monitoring metric meets the expected rhythm criteria based on a comparison of the redetermined monitoring metric to the first event monitoring threshold.

18 . The method claim 16 , wherein determining the monitoring metric comprises determining an integration metric of the first cardiac signal by summing sample points of the first cardiac signal sensed over an integration time period comprising a plurality of cardiac cycles.

19 . The method of claim 18 , further comprising:

determining an atrial rate; and

determining the monitoring metric by normalizing the integration metric by the atrial rate.

20 . The method of claim 18 , further comprising:

determining a first event monitoring threshold by:

determining the integration metric from the first cardiac signal over each one of a plurality of integration time intervals occurring within a first time interval, where each one of the plurality of integration time intervals extends over a plurality of cardiac cycles; and

determining the first event monitoring threshold based on the integration metrics determined from the first cardiac signal sensed during the first time interval;

re-determining the integration metric from the first cardiac signal sensed over at least one integration time interval occurring during a second time interval after the first time interval;

determining that the re-determined integration metric is greater than the first event monitoring threshold; and

determining that the expected rhythm criteria are met in response to the re-determined integration metric being greater than the first event monitoring threshold.

21 . The method of claim 20 , where setting the first event monitoring threshold further comprises:

identifying a minimum integration metric from the integration metrics determined over each one of the plurality of integration time intervals occurring during the first time interval; and

setting the event monitoring threshold based on the minimum integration metric.

22 . The method of claim 16 , wherein determining the monitoring metric comprises:

identifying a plurality of ventricular events from the first cardiac signal; and

determining the monitoring metric based on the identified plurality of ventricular events by determining at least one of:

a ventricular event rate;

an atrioventricular time interval; and

a ratio of a count of the plurality of ventricular events to a count of atrial events occurring over a time interval comprising the identified plurality of ventricular events.

23 . The method of claim 22 , further comprising:

setting an event monitoring threshold; and

identifying the plurality of ventricular events from the first cardiac signal based on the first cardiac signal crossing the event monitoring threshold.

24 . The method of claim 23 , wherein setting the event monitoring threshold comprises:

setting a blanking interval in response to each of the plurality of atrial events

determining a maximum amplitude of the first cardiac signal outside the blanking interval; and

setting the event monitoring threshold based on the maximum amplitude.

25 . The method of claim 16 , further comprising:

setting a first event monitoring threshold;

determining the monitoring metric from the first cardiac signal sensed during a first time interval;

determining, based on the first event monitoring threshold, that the monitoring metric determined from the first cardiac signal sensed during the first time interval does not meet the expected rhythm criteria;

adjusting the first event monitoring threshold to a second event monitoring threshold;

re-determining the monitoring metric from the first cardiac signal sensed during a second time interval after the first time interval;

determining, based on the second event monitoring threshold, that the re-determined monitoring metric determined from the first cardiac signal sensed during the second time interval meets the expected rhythm criteria; and

enabling the at least one monitoring feature of the medical device in response to the redetermined monitoring metric meeting the expected rhythm criteria.

26 . The method of claim 16 , further comprising:

determining that the monitoring metric determined from the first cardiac signal does not meet the expected rhythm criteria;

sensing a second cardiac signal different than the first cardiac signal;

determining a second monitoring metric from the second cardiac signal;

determining that the second monitoring metric meets the expected rhythm criteria; and

enabling the at least one monitoring feature of the medical device that is based on processing and analysis of the second cardiac signal in response to the second monitoring metric meeting the expected rhythm criteria.

27 . The method of claim 16 , comprising sensing the first cardiac signal as an acceleration signal.

28 . The method of claim 16 , comprising:

sensing the first cardiac signal as a cardiac electrical signal;

setting a far field R-wave detection threshold;

sensing far field R-waves from the cardiac electrical signal based on the far field R-wave detection threshold; and

determining the monitoring metric based on the sensed far field R-waves.

29 . The method of claim 16 , further comprising:

sensing a second cardiac signal different than the first cardiac signal;

determining that the second cardiac signal meets second expected rhythm criteria; and

enabling the at least one monitoring feature of the medical device that is based on processing and analysis of the first cardiac signal and the second cardiac signal in response to the monitoring metric determined from the first cardiac signal meeting the expected rhythm criteria and the second cardiac signal meeting second expected rhythm criteria.

30 . A non-transitory, computer-readable storage medium comprising a set of instructions which, when executed by a control circuit of a medical device, cause the medical device to:

sense a cardiac signal

determine a monitoring metric representative of activity of at least one heart chamber from the cardiac signal;

determine if the monitoring metric meets expected rhythm criteria by determining if the monitoring metric meets atrioventricular conduction criteria; and

in response to determining that the monitoring metric meets atrioventricular conduction criteria:

determine that the first cardiac signal is reliable for use by a monitoring feature of the medical device; and

enable at least one monitoring feature of the medical device that is based on processing and analysis of the first cardiac signal by at least enabling an atrioventricular block monitoring feature; and

in response to determining that the monitoring metric does not meet the atrioventricular conduction criteria:

determine that the first cardiac signal is not reliable for use by a monitoring feature of the medical device; and

disable at least one monitoring feature of the medical device by at least disabling the atrioventricular block monitoring feature.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2021
From: GALARNEAU, MICHELLE M.; GREENHUT, SAUL E.; GRINBERG, YANINA; SHELDON, TODD J.
To: MEDTRONIC, INC. (CVG)
Reel/Frame 057065/0592 →
Continuity (2)
Provisional Application 63070325 · Aug 26, 2020
Related Publication 20220062646A1 · Mar 3, 2022
References Cited (31)
US 4485813A · Anderson et al. · 1984 [cited by applicant]
US 5052388A · Sivula et al. · 1991 [cited by applicant]
US 5507782A · Kieval et al. · 1996 [cited by applicant]
US 5593431A · Sheldon · 1997 [cited by applicant]
US 5683426A · Greenhut et al. · 1997 [cited by applicant]
US 5885471A · Ruben et al. · 1999 [cited by applicant]
US 6044297A · Sheldon et al. · 2000 [cited by applicant]
US 6434428B1 · Sloman et al. · 2002 [cited by applicant]
US 8204593B2 · Sheldon et al. · 2012 [cited by applicant]
US 8731662B2 · Imran · 2014 [cited by applicant]
US 8788028B2 · Kumar et al. · 2014 [cited by applicant]
US 9592391B2 · Stahmann et al. · 2017 [cited by applicant]
US 10463866B2 · Stahmann et al. · 2019 [cited by applicant]
US 20080234771A1 · Chinchoy et al. · 2008 [cited by applicant]
US 20120095521A1 · Hintz · 2012 [cited by applicant]
US 20120215274A1 · Koh et al. · 2012 [cited by applicant]
US 20140121720A1 · Bonner et al. · 2014 [cited by applicant]
US 20160015984A1 · Demmer et al. · 2016 [cited by applicant]
US 20160175603A1 · Sheldon et al. · 2016 [cited by applicant]
US 20160310733A1 · Sheldon · 2016 [cited by examiner]
US 20180028087A1 · Zhang · 2018 [cited by examiner]
US 20180361160A1 · Sheldon · 2018 [cited by examiner]
US 20190083779A1 · Yang et al. · 2019 [cited by applicant]
US 20190298210A1 · Bennet et al. · 2019 [cited by applicant]
US 20200269055A1 · Kleckner · 2020 [cited by examiner]
US 20200376280A1 · Shuros · 2020 [cited by examiner]
US 20200406041A1 · Cao · 2020 [cited by examiner]
WO 2006086435A2 · 2006 [cited by applicant]
WO 2016118508A1 · 2016 [cited by applicant]
(PCT/US2021/045154) PCT Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, Mailed Nov. 10, 2021, 9 pages. [cited by applicant]
Galarneau, et al., U.S. Appl. No. 63/006,208, entitled “Medical Device and Method for Detecting Atrioventricular Block,” filed Apr. 7, 2020, 84 pages. [cited by applicant]